Erica Franceschini Selected Research

Erica Franceschini Research Topics

Disease

21	COVID-19 01/2024 - 01/2020
17	Infections 03/2024 - 10/2016
10	Pneumonia (Pneumonitis) 01/2024 - 01/2020
4	Critical Illness (Critically Ill) 10/2023 - 07/2022
3	Sepsis (Septicemia) 03/2024 - 01/2020
3	Bacterial Infections (Bacterial Infection) 11/2023 - 01/2022
3	Bacteremia 01/2023 - 01/2019
3	Fever (Fevers) 04/2022 - 06/2017
2	Fibrosis (Cirrhosis) 03/2023 - 01/2022
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2020
1	Septic Shock (Toxic Shock Syndrome) 03/2024
1	Pain (Aches) 01/2024
1	Endocarditis 11/2023
1	Pressure Ulcer (Bedsore) 11/2023
1	Cachexia 11/2023
1	Febrile Neutropenia 11/2023
1	Disease Progression 11/2023
1	Venous Thromboembolism 10/2023
1	Myocardial Infarction 10/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023
1	Hematologic Neoplasms (Hematological Malignancy) 10/2023
1	Clostridium Infections 06/2023
1	Alcoholism (Alcohol Abuse) 04/2023
1	Encephalitis (Encephalitis, Rasmussen) 03/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2023
1	Alcoholic Hepatitis 03/2023
1	Acute-On-Chronic Liver Failure 03/2023
1	Blackwater Fever 01/2023
1	Ventilator-Associated Pneumonia 07/2022
1	Fatigue 04/2022
1	Nausea 04/2022
1	Vomiting 04/2022
1	Alkalosis 02/2022
1	Respiratory Acidosis 02/2022
1	Acidosis 02/2022
1	Respiratory Alkalosis 02/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Invasive Fungal Infections 08/2021
1	Mycoses (Diseases, Fungus) 08/2021
1	Inflammation (Inflammations) 08/2021

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 01/2019
7	tocilizumab (atlizumab)FDA Link 01/2023 - 08/2020
4	SteroidsIBA 03/2023 - 09/2021
3	Antiviral Agents (Antivirals)IBA 11/2023 - 01/2022
3	AntibodiesIBA 10/2023 - 01/2022
3	Carbapenems (Carbapenem Antibiotics)IBA 07/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2021
2	Immunoglobulin G (IgG)IBA 01/2024 - 01/2022
2	Monoclonal AntibodiesIBA 01/2024 - 11/2023
2	VaccinesIBA 11/2023 - 04/2022
2	AnticoagulantsIBA 10/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 10/2023 - 01/2022
2	GlucocorticoidsIBA 03/2023 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023 - 01/2021
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2021
1	Fosfomycin FDA Link 03/2024
1	tazobactam drug combination ceftolozaneIBA 03/2024
1	Cocaine (Cocaine HCl)IBA 01/2024
1	casirivimab and imdevimab drug combinationIBA 01/2024
1	dalbavancinIBA 11/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2023
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2023
1	Rituximab (Mabthera)FDA Link 10/2023
1	obinutuzumabIBA 10/2023
1	Bendamustine Hydrochloride FDA Link 10/2023
1	bezlotoxumabIBA 06/2023
1	Vancomycin FDA LinkGeneric 06/2023
1	FidaxomicinIBA 06/2023
1	molnupiravirIBA 12/2022
1	nirmatrelvir and ritonavir drug combinationIBA 12/2022
1	ceftazidime drug combination avibactamIBA 07/2022
1	2019-nCoV Vaccine mRNA-1273IBA 04/2022
1	AcidsIBA 02/2022
1	EnzymesIBA 01/2022
1	CytokinesIBA 01/2022
1	AntigensIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	RB 6145IBA 01/2022
1	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 01/2022
1	CollagenIBA 01/2022
1	CefiderocolIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 08/2021
1	Sodium Glutamate (Accent)IBA 08/2021
1	CreatinineIBA 06/2021

Therapy/Procedure

19	Therapeutics 03/2024 - 10/2016
10	Artificial Respiration (Mechanical Ventilation) 01/2024 - 01/2020
6	Length of Stay 11/2023 - 10/2016
6	Liver Transplantation 06/2023 - 08/2012
2	Critical Care (Surgical Intensive Care) 03/2024 - 04/2023
2	Duration of Therapy 01/2023 - 06/2022
2	Immunomodulation 01/2021 - 01/2021
2	Kidney Transplantation 01/2018 - 07/2017
1	Precision Medicine 03/2024
1	Prostheses and Implants (Prosthesis) 11/2023
1	Central Venous Catheters 11/2023
1	Transplantation 11/2023
1	Continuous Positive Airway Pressure 10/2023
1	Noninvasive Ventilation 10/2023
1	Renal Dialysis (Hemodialysis) 04/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2021